An interventional study of BasketballRx in Pediatric Obesity, Pediatric Overweight and Anxiety, sponsored by Milton S. Hershey Medical Center. Completed at 2 sites in United States. Open to participants aged 10 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Milton S. Hershey Medical Center · Not applicable, Interventional, and Treatment
Among 558 studies in Pediatric Obesity with a site in United States — 76 open to participants now, 111 under way, 3 of them phase 3. Pediatric Obesity · United States.
Among the 558 studies in Pediatric Obesity with a site in United States, this one is the 453rd largest by enrollment of the 475 interventional ones that give a count, is one of 14 that started in 2026, is one of 422 with no phase, and was the 555th registered.
1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.
Browse Pediatric Obesity studies →76 of the 558 studies in Pediatric Obesity with a site in United States are open now. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 10–15
Children's Hospital Los Angeles · Sites in United States
Ages 12–18
Virginia Commonwealth University · Sites in United States
Ages 12–15 · Healthy volunteers
University of Michigan · Sites in United States
Ages 4 mo+ · Healthy volunteers
Russell McCulloh, MD · Sites in United States
Ages 12–17
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 124 Pediatric Obesity studies recruiting now, 19 (15%) set no upper age limit and 103 (83%) stop at 75 or younger; 114 take children under 18; 69 take healthy volunteers.
This study: 10 Years to 15 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
558 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 28 · Phase 3 10 · Phase 4 11
First in 1998; this study’s year is marked. 14 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 8 is below the median of 100 across 870 interventional studies indexed under Pediatric Obesity.
Median enrollment 95 across the 475 interventional studies, 120 across the 81 observational. Of the 417 that completed or were terminated, 116 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 558 have an industry lead sponsor. The 10 most frequent:
Milton S. Hershey Medical Center is the lead sponsor of 492 studies on the registry; 60 are open to participants now.
Of its 58 completed or terminated interventional studies of FDA-regulated products, 46 (79%) have results posted.
Milton S. Hershey Medical Center has 4 studies filed under Pediatric Obesity — fewer than ten, so there is no comparison to draw.
38 of the studies in Pediatric Obesity with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04974554Medical University of South CarolinaFIT Families Multicomponent Obesity Intervention for African American Adolescents | 2026-11-30 |
| NCT06810557Temple UniversityBrief Behavioral Sleep Intervention for Obesity Prevention in Primary Care | 2026-11-30 |
| NCT05067621Yale UniversitySemaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease | 2026-12 |
| NCT04128995Children's Hospital Medical Center, CincinnatiSurgical or Medical Treatment | 2026-12 |
| NCT04752293Wake Forest University Health SciencesPediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) | 2026-12 |
Among the 558 studies in Pediatric Obesity with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to learn if BasketballRx, a basketball and health program, works well for children and teens who are overweight or have obesity. The study will also look at whether the program helps children build healthy habits, improve their health, and feel better.
The main questions the BasketballRx clinical trial aims to answer are:
Participants will:
BasketballRx is a pilot study for children ages 10 to 15 who are overweight or have obesity. The study will help researchers learn if the program works well for children and families and if it may help children build healthier habits, improve their physical health, and support their emotional well-being. Up to 30 children will take part.
Children will attend six BasketballRx sessions over about two months. The first five sessions will last 90 minutes. Each session will include a health lesson and basketball activities. Children will learn about healthy eating, drinking enough water, reading food labels, sleep, injury prevention, mindfulness, and ways to manage stress. They will also take part in basketball drills, games, and team activities designed for their age and skill level.
The last session will be a three-hour "Hoops for Health Fair." Children will take part in basketball games and activities and share some of what they learned during the program with their families and community members.
Researchers will look at how well the program works for children and families. They will track how many children join the study, attend the sessions, and complete the program. Children will also be asked what they thought about BasketballRx.
Researchers will also look for changes in children's health and healthy habits. Height, weight, and waist size will be measured at the beginning and end of the program. Blood pressure and heart rate will be checked before physical activity at each session. Children will answer questions about healthy eating, physical activity, sleep, screen time, stress, mood, and other health habits. They will also complete standard questionnaires about feelings of anxiety and depression. If a child's answers show that they may need more support, the study team will follow the study safety plan and may recommend follow-up with the child's regular healthcare provider.
Because this is a small pilot study, the main goal is to learn whether BasketballRx is practical and works well for children and families. Researchers will also look for early signs that the program may help improve healthy habits, physical health, and emotional well-being. What is learned from this study may be used to improve BasketballRx and plan larger studies in the future.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
EXCLUSION CRITERIA:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.
The study may name a correction formula and a limit in milliseconds, often around 450–480.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
QT and QTc
On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.
The study may name a correction formula and a limit in milliseconds, often around 450–480.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive the BasketballRx intervention, a community-based health and wellness program that combines health education with structured basketball activities. Participants will attend six sessions over approximately two months. Sessions 1 through 5 will each last 90 minutes and include 40 minutes of interactive health education and 50 minutes of age-appropriate basketball activities. Health topics will include nutrition, hydration, reading food labels, healthy eating, sleep, injury prevention, mindfulness, and stress management. Basketball activities will include warm-ups, skill-building drills, games, and team activities designed to promote physical activity and teamwork. Session 6 will be a three-hour "Hoops for Health Fair." Participants will take part in basketball games and skill activities and share what they learned about healthy living with family and community members.
Behavioral: BasketballRx
BasketballRx is a youth health and wellness program that combines interactive health education with structured basketball activities. The program teaches healthy habits related to nutrition, hydration, sleep, physical activity, mindfulness, and stress management while providing age-appropriate basketball activities that promote physical activity and teamwork. Participants complete six sessions over approximately two months.
Change from baseline in the BMI at 2 months
BMI will be calculated from measured height and weight and expressed in kg/m². BMI will be assessed at baseline (prior to the BasketballRx intervention) and at approximately 2 months after completion of the intervention. Change in BMI will be calculated as the post-intervention BMI minus the baseline BMI.
Time frame: Baseline and approximately 2 months after completion of the BasketballRx intervention.
Change in self-reported physical activity, nutrition, and sleep habits at 2months.
Participants will complete a survey at baseline and at the end of the BasketballRx intervention to assess physical activity, nutrition, and sleep habits. Changes in self-reported health behaviors will be assessed by comparing responses before and after the BasketballRx intervention.
Time frame: 2 months
Change in waist circumference at 2 months.
Waist circumference will be measured in centimeters at baseline and at approximately 2 months. Change in waist circumference will be calculated as the difference between the baseline and post-intervention measurements.
Time frame: 2 months
Program attendance and completion rates.
Program attendance will be measured as the number and percentage of BasketballRx sessions attended by each participant. Program completion will be measured as the number and percentage of participants who meet the study-defined criteria for completing the BasketballRx program.
Time frame: 2 months
Change in anxiety and depression levels.
Anxiety and depression symptoms will be assessed at baseline and at completion of the BasketballRx intervention. Anxiety symptoms will be measured using the Screen for Child Anxiety Related Disorders (SCARED), and depression symptoms will be measured using the Patient Health Questionnaire-2 (PHQ-2). Participants with a PHQ-2 score of 3 or greater will complete the Patient Health Questionnaire-Adolescent (PHQ-A) for further assessment. Changes in anxiety and depression scores will be assessed by comparing baseline and post-intervention scores.
Time frame: 2 months
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Individual participant data will not be shared because this is a small pilot study involving minors and includes potentially sensitive health information. Given the small sample size, there is an increased risk of participant re-identification even after direct identifiers are removed.
Ran from Mar 2026 to primary completion in Aug 2026, 5 months.
Of 539 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's 5 months is below that.
Counting every sponsor, half of 541 studies reached it within 25 months; a quarter within 11 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Milton S. Hershey Medical Center →